BioSpace News Archive

Bexion Pharmaceuticals, Inc. announced today that it has added RJ. Tesi, M.D. to its Board of Directors. Dr. Tesi has a distinguished career as a biotech entrepreneur and an experienced surgeon. C

MedCrypt Inc., the leading provider of proactive security solutions for the healthcare space, today announced Accuray has chosen MedCrypt’s Software Bill of Materials (SBOM) and Vulnerability Tracking Software, Heimdall, to help enhance monitoring the digital security posture of the company’s portfolio of radiation treatment delivery, planning, and data management solutions.

EmpiRx Health, the industry’s only value-based pharmacy benefit manager (PBM), today announced it has appointed David Busch as chief growth officer.

Hamilton Health Sciences is taking the next step toward digital transformation by renewing its hospital information system.

Huntington Hospital announced that Pamela Weatherspoon, MBA, is joining the hospital’s executive management team as Vice President, Enterprise Diversity, Equity and Inclusion, a new role within the organization.

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced today that both data abstracts for Painful Diabetic Neuropathy (PDN) and Non-Surgical Refractory Back Pain (NSRBP) were accepted by the North American Neuromodulation Society (NANS 2021)

BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to announce that it has closed a brokered private placement (the “Offering”) of an unsecured convertible debenture unit of the Company (the “Unit”) to a single subscriber, purchased at a price of $375,000

BIOLASE, Inc., the global leader in dental lasers, completed its leadership council meeting of the Waterlase Endo Academy on Nov. 14, forming an exclusive community of leading endodontists, dedicated to improving patient outcomes and profitability with new technology.

VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration agreement with CERIMED (European Centre for Research in Medical Imaging) to support the preclinical development of VECT-HORUS’ theragnostic agents.

ZOLL Medical Corporation and the U.S. Air Force Research Laboratory announced the signing of a patent license agreement to make it easier for the deployed medic to document vitals, help administer critical care, integrate patient data and identify exact location of casualties in austere combat environments.